Kyungki-do, South Korea

Su-Eon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Dong-A Pharmaceutical Co., Ltd. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su-Eon Kim. Retrieved from https://idiyas.com/inventor/su-eon-kim-le1i0nwx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Su-Eon Kim: Innovator in Pharmaceutical Solutions

Introduction

Su-Eon Kim is a prominent inventor based in Kyungki-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in enhancing the solubility of drugs. Her innovative work has the potential to improve the efficacy of oral medications.

Latest Patents

Su-Eon Kim holds a patent for "Intraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same." This patent focuses on reducing the particle diameter of itraconazole, an insoluble drug, and changing its crystallinity from crystalline to amorphous. This transformation increases the water solubility and dissolution rate of the drug, making it more effective for oral administration.

Career Highlights

Su-Eon Kim is currently associated with Dong-A Pharmaceutical Co., Ltd., where she continues to innovate in the pharmaceutical sector. Her work is crucial in developing new formulations that can enhance drug delivery and patient outcomes.

Collaborations

Some of her notable coworkers include Bong-Jin Cha and Jun-Gyo Oh, who contribute to her research and development efforts.

Conclusion

Su-Eon Kim's contributions to pharmaceutical innovations demonstrate her commitment to improving drug solubility and efficacy. Her work is paving the way for advancements in oral medication formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…